Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Verzetti, G.
Right arrow Articles by Panzetta, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verzetti, G.
Right arrow Articles by Panzetta, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 4 955-961, Copyright © 1998 by Oxford University Press


ORIGINAL ARTICLES

Acetate-free biofiltration versus bicarbonate haemodialysis in the treatment of patients with diabetic nephropathy: a cross-over multicentric study

G Verzetti, C Navino, R Bolzani, G Galli and G Panzetta
Divisione di Nefrologia e Dialisi, Ospedale Maggiore della Carita, Novara, Italy; Dipartimento di Statistica, Universita di Modena, Italy; Servizio di Nefrologia e Dialisi, Ospedale Maggiore, Trieste, Italy; Corresponding author

Background: Morbidity and mortality rates in diabetic patients on regular dialysis treatment (RDT) are higher than in non-diabetic-subjects on RDT. Moreover diabetic patients experience an intradialytic morbidity unacceptably higher than in patients with other causes of terminal renal failure. The aim of the present investigation was to compare standard bicarbonate haemodialysis (BHD) with acetate-free biofiltration (AFB) in a group of 41 diabetic patients stable on dialysis treatment for 25±22 months. Methods: Twenty four type II and 17 type I diabetic patients, all requiring insulin therapy, were included and were followed for 1 year in a 6-month cross-over randomized study for both methods. The analysis was carried out on dialysis symptoms, interdialysis symptoms, and nutritional status, and the multivariate analysis of variance for repeated measures on the same subjects in the two techniques was used. Results: AFB significantly reduced dialytic and extradialytic symptoms (P=0.003 and 0.001 respectively). Cardiovascular collapses decreased by 43%, and other dialysis symptoms showed a similar trend (-35%). The interdialysis symptoms decreased by 28% and were accompanied by an increase in subjective wellbeing (39%) when patients were switched from traditional haemodialysis to AFB. Acid-base control was better with AFB (P=0.01), both at the beginning and during the session. Slightly significant differences were also obtained for Kt/V (AFB 1.48±0.29 vs BHD 1.38±0.30), while no significant difference was noted with respect to sodium mass balance, nutritional status, calorie-protein intake, nPCR, blood glucose profile, and insulin requirements. The number of hospital admissions and the mortality rate, which were much lower during the AFB than the BHD period, were not analysed statistically. Conclusions: AFB allows better control of some metabolic aspects, reduces intra- and extradialysis symptoms, and improves patient quality of life. Whether the long-term prognosis can be improved by AFB remains to be established with further studies. Key words: acetate-free biofiltration; bicarbonate haemodialysis; diabetic nephropathy; morbidity rates; RDT
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
G. Panzetta, C. Basile, A. Santoro, E. Ancarani, S. Costantini, F. Guarnieri, and G. Verzetti
Diabetics on dialysis in Italy: a nationwide epidemiological study
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3988 - 3995.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. Grandi, M. Govoni, S. Furini, S. Severi, E. Giordano, A. Santoro, and S. Cavalcanti
Induction of NO synthase 2 in ventricular cardiomyocytes incubated with a conventional bicarbonate dialysis bath
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2192 - 2197.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Locatelli, A. Covic, C. Chazot, K. Leunissen, J. Luno, and M. Yaqoob
Optimal composition of the dialysate, with emphasis on its influence on blood pressure
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 785 - 796.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Perez-Garcia, P. R. Benitez, E. Verde, and F. Valderrabano
Increasing of renal replacement therapy (RRT) in diabetic patients in Madrid
Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2525 - 2527.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.